Amoaku, Winfried

Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

Holz, F. G., Amoaku, W., Donate, J., Guymer, R. H., Kellner, U., Schlingemann, R. O., Weichselberger, A., & Staurenghi, G. (2011) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 413

Defining response to anti-VEGF therapies in neovascular AMD

Amoaku, W. M., Chakravarthy, U., Gale, R., Gavin, M., Ghanchi, F., Gibson, J., Harding, S., Johnston, R. L., Kelly, S., Lotery, A., et al. (2015) · Eye

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 355

Diabetic retinopathy for the non-ophthalmologist

Fung, T. H., Patel, B., Wilmot, E. G., & Amoaku, W. M. (2022) · Clinical Medicine

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 151

Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment

Amoaku, W. (2009) · Eye

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 29

Electrophysiological and microperimetry changes in vitamin A deficiency retinopathy

Saker, S., Morales, M., Jhittay, H., Wen, Y., & Amoaku, W. (2015) · Documenta Ophthalmologica

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 13